However, we found that most acute myeloid leukemia (AML) cells, especially M4 and M5 subtypes, produce TNF and show basal level activation of RIP1/RIP3/MLKL signaling, yet do not undergo necroptosis.

The majority of patients with acute myeloid leukemia (AML) under 60 years of ... The combination of peptide vaccines with donor lymphocyte infusions is feasible. The term 'vaccine-enhanced donor ...